Bank Julius Baer & Co. Ltd, Zurich Merck & Co., Inc. Transaction History
Bank Julius Baer & Co. Ltd, Zurich
- $27 Billion
- Q1 2025
A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 2,626,227 shares of MRK stock, worth $211 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
2,626,227
Previous 1,110,372
136.52%
Holding current value
$211 Million
Previous $110 Million
113.41%
% of portfolio
0.87%
Previous 0.38%
Shares
24 transactions
Others Institutions Holding MRK
# of Institutions
3,832Shares Held
1.97BCall Options Held
25.2MPut Options Held
24.5M-
Vanguard Group Inc Valley Forge, PA253MShares$20.3 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.68 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.56 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.73 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $203B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...